The Investigational Products Facility’s mission is to ensure the quality and regulatory compliance of Memorial Sloan Kettering Cancer Center’s clinical trials investigational products and Investigational New Drug (IND) applications, and to promote efficiency in our drug development projects, through a combination of advisory, project management, and quality assurance (QA) oversight services.